NCT00340431View on ClinicalTrials.gov

Experimental Vaccine for Plasmodium Falciparum Malaria

PHASE1CompletedINTERVENTIONAL
0
Timeline

Start Date

June 9, 2004

Study Completion Date

February 6, 2008

Conditions
Plasmodium Falciparum MalariaVaccines
Interventions
DRUG

MSP1(42)-FVO & MSP1(42)-3D7

Trial Locations (1)

Unknown

Quintiles Phase 1 Services, Lenexa

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00340431 - Experimental Vaccine for Plasmodium Falciparum Malaria | Biotech Hunter | Biotech Hunter